NASDAQ:MRAI Marpai (MRAI) Stock Price, News & Analysis $0.68 +0.06 (+9.68%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.66▼$0.6850-Day Range$0.50▼$2.0052-Week Range$0.33▼$3.46Volume269 shsAverage Volume423,240 shsMarket Capitalization$7.50 millionP/E RatioN/ADividend YieldN/APrice Target$6.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Marpai alerts: Email Address Ad WealthPressThis TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.But I can promise that you’ll see all the details for yourself here. About Marpai Stock (NASDAQ:MRAI)Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.Read More MRAI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MRAI Stock News HeadlinesJuly 16, 2024 | prnewswire.comMARPAI PRESIDENT JOHN POWERS TABBED TO SPEAK AT 3 ELITE HEALTHCARE CONFERENCESMay 28, 2024 | investorplace.comWhy Is Marpai (MRAI) Stock Down 41% Today?July 26, 2024 | WealthPress (Ad)New trading system called MSFT, NVDA & MSFTLook 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.May 24, 2024 | prnewswire.comMARPAI ANNOUNCES WITHDRAWAL FROM NASDAQ HEARINGS PROCESS AND WILL TRANSITION TRADING TO THE OTCQX MARKETMay 21, 2024 | prnewswire.comSHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Marpai, Inc. (NASDAQ: MRAI)May 13, 2024 | finance.yahoo.comMarpai Inc (MRAI) Q1 2024 Earnings Call Transcript Highlights: Strategic Shifts and Financial ...May 11, 2024 | markets.businessinsider.comMarpai’s Strategic Turnaround and Growth Potential Justify Buy RatingMay 11, 2024 | finance.yahoo.comMarpai, Inc. (NASDAQ:MRAI) Q1 2024 Earnings Call TranscriptJuly 26, 2024 | WealthPress (Ad)New trading system called MSFT, NVDA & MSFTLook 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.May 9, 2024 | investorplace.comMRAI Stock Earnings: Marpai Reported Results for Q1 2024May 9, 2024 | prnewswire.comMARPAI REPORTS FIRST QUARTER 2024 FINANCIAL RESULTSMay 3, 2024 | prnewswire.comMARPAI TO HOST WEBCAST ON MAY 10, 2024 TO DISCUSS FIRST QUARTER 2024 FINANCIAL RESULTSMay 2, 2024 | prnewswire.comMARPAI INC. ANNOUNCES COST REDUCTION PROGRAM AND PROPERTY SUBLEASEApril 24, 2024 | prnewswire.comMARPAI INC. BOLSTERS SALES TEAM WITH TWO WORLD-CLASS EXECUTIVESApril 18, 2024 | investing.comMarpai secures $11.83 million in convertible notesApril 16, 2024 | prnewswire.comMARPAI INC. ANNOUNCES SALE OF $11.83 MILLION CONVERTIBLE NOTESApril 4, 2024 | benzinga.comMarpai Stock (NASDAQ:MRAI), Quotes and News SummaryMarch 29, 2024 | seekingalpha.comMarpai, Inc. (MRAI) Q4 2023 Earnings Call TranscriptSee More Headlines Receive MRAI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Marpai and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today7/26/2024Next Earnings (Estimated)8/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A Current SymbolNASDAQ:MRAI CUSIPN/A CIK1844392 Webwww.marpaihealth.com Phone646-303-3483FaxN/AEmployees162Year FoundedN/APrice Target and Rating Average Stock Price Target$6.00 High Stock Price Target$6.00 Low Stock Price Target$6.00 Potential Upside/Downside+782.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($3.19) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-28,750,000.00 Net Margins-69.48% Pretax Margin-70.31% Return on EquityN/A Return on Assets-68.67% Debt Debt-to-Equity RatioN/A Current Ratio0.82 Quick Ratio0.82 Sales & Book Value Annual Sales$37.15 million Price / Sales0.20 Cash FlowN/A Price / Cash FlowN/A Book Value($1.72) per share Price / Book-0.40Miscellaneous Outstanding Shares11,040,000Free Float4,269,000Market Cap$7.50 million OptionableNo Data Beta4.87 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Damien Francis Lamendola (Age 67)CEO & Director Mr. Steve Johnson (Age 53)CFO & Company Secretary Mr. John Powers (Age 56)President & COO Dr. Eli David (Age 42)Co-Founder & Chief Science Advisor Ms. Pamela BurnsVice President of Enterprise SalesMr. Richard BrewerChief Strategy OfficerMore ExecutivesKey CompetitorsOntrakNASDAQ:OTRKBioRestorative TherapiesNASDAQ:BRTXMangoceuticalsNASDAQ:MGRXGreenbrook TMSNASDAQ:GBNHFGlobal Cord BloodNYSE:CORBFView All CompetitorsInsidersSteve Andrew JohnsonBought 3,500 shares on 5/29/2024Total: $2,275.00 ($0.65/share)Robert M PonsBought 5,000 shares on 5/28/2024Total: $4,350.00 ($0.87/share)Steve Andrew JohnsonBought 5,000 shares on 5/24/2024Total: $6,000.00 ($1.20/share)Damien LamendolaBought 910,000 shares on 3/7/2024Total: $1.50 M ($1.65/share)Damien LamendolaBought 1,100,000 shares on 1/16/2024Total: $1.01 M ($0.92/share)View All Insider Transactions MRAI Stock Analysis - Frequently Asked Questions How have MRAI shares performed this year? Marpai's stock was trading at $1.75 at the beginning of the year. Since then, MRAI stock has decreased by 61.2% and is now trading at $0.6798. View the best growth stocks for 2024 here. How were Marpai's earnings last quarter? Marpai, Inc. (NASDAQ:MRAI) released its quarterly earnings results on Thursday, May, 9th. The company reported ($0.46) earnings per share (EPS) for the quarter. The company had revenue of $7.39 million for the quarter. When did Marpai's stock split? Shares of Marpai reverse split on the morning of Thursday, June 29th 2023. The 1-4 reverse split was announced on Thursday, June 29th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 29th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split. When did Marpai IPO? Marpai (MRAI) raised $25 million in an initial public offering (IPO) on Wednesday, October 27th 2021. The company issued 6,300,000 shares at a price of $4.00 per share. ThinkEquity served as the underwriter for the IPO. How do I buy shares of Marpai? Shares of MRAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MRAI) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marpai, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marpai With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.